| Literature DB >> 28787448 |
Yu Wang1, Jialing Li2, Weibin Sun3, Huang Li2, Richard D Cannon4, Li Mei4.
Abstract
OBJECTIVE: To assess the effect of non-fluoride agents on the prevention of dental caries in primary dentition.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28787448 PMCID: PMC5546704 DOI: 10.1371/journal.pone.0182221
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Systematic review flow diagram.
(RCT = Randomized controlled trials).
Summary of the included studies.
| Type of intervention | First Author (year) | Participants invention/control (age) | Follow-up protocol | Intervention modality | Comparative/control | Assessment method | Primary outcome |
|---|---|---|---|---|---|---|---|
| Arginine | Acevedo,AM. (2008) | 96/99 subjects (10.5-11y) | Baseline, 6, 12m | Confection containing CaviStat® + F toothpaste,4 times a day | Control confection without CaviStat® + F toothpaste | defs scores | Test / control (Mean±SD) |
| defs: | |||||||
| 0m: 0.67±1.66 / 0.51±1.21 | |||||||
| 6m: 0.95±1.46 / 1.29±1.85 | |||||||
| 12m: 0.81±1.43 / 1.09±1.57 | |||||||
| Chlorhexidine | Gisselsson, H. (1994) | 59/58/116 subjects (4-7y) | Baseline, 3y | (1)1% chlorhexidine gel,4 times a year | (1) Placebo gel,4 times a year | defs scores | Test/placebo/control (Mean±SD) |
| (2) Control group (no treatment) | Baseline: 0.19/0.03/0.4 | ||||||
| 3 years: 2.78±3.27/4.57±4.04/4.6±4.86 | |||||||
| Tai, B.J. (2003) | 440/451/415 subjects (3-7y) | Baseline, 2y | 40% chlorhexidine varnish, once every 6 months | (1) Placebo varnish, once every 6 month | defs scores/dmfs molar scores | Test/placebo/control (Mean±SD) | |
| (2) No treatment | 3yrs group: | ||||||
| Baseline: 2.98±4.72/4.20±5.86/4.6±4.86 | |||||||
| 2 years: 4.20±5.86/4.64±5.45/4.11±5.68 | |||||||
| 5yrs group: | |||||||
| Baseline: 2.81±4.22/2.63±4.14/3.07±4.23 | |||||||
| 2 years: 3.81±4.58/4.24±4.93/4.9±5.2 | |||||||
| 6-7yrs group: | |||||||
| Baseline: 0.25±0.75/0.41±0.85/0.3±0.93 | |||||||
| 2 years: 0.52±1.41/0.9±1.28/1.77±1.44 | |||||||
| Baca, P. (2004) | 86/95 subjects (6-7y) | Baseline, 2y | (1) 1% chlorhexidine-thymol varnish, once every 3 months | Control group (no treatment) | dmft and dmfs scores | Test/ control (Mean±SD) | |
| dmfs: | |||||||
| Baseline: 3.75±6.75/3.07±6.03 | |||||||
| 2y:(dft = 0 at baseline) 0.94±2.10/1.73±2.68 | |||||||
| (dft>0 at baseline) 3.04±3.15/3.4±3.88 | |||||||
| Du, M.Q. (2006) | 155/135 subjects (4-5y) | Baseline, 2y | 40% chlorhexidine varnish, once every 6 months | Placebo varnish, once every 6 month | dmfs molar scores | Test/control (Mean±SD) | |
| dmfs-molar: | |||||||
| Baseline: 2.8±0.3/2.6±0.4 | |||||||
| 2y:3.8±0.4/4.2±0.4 | |||||||
| Amorim, R.G. (2008) | 18/19/20/19 subjects (3-5y) | Baseline, 3m | (1) Chlorhexidine varnish | Control group (no treatment) | Clinical assessment was performed at 1 m and 3 m follow-up with VPI and WS scores | Test1/test 2/test 3/control (Mean ±SD) | |
| (2) Fluoride varnish | WS score (T1-T3): | ||||||
| (3) Chlorhexidine and fluoride varnish once every week,4 times. | -0.89±1.45/-1.05±1.54/-1.4±2.21 / 0.37±1.01 | ||||||
| Plonka, K.A (2013) | 183/171/188 subjects (6-24m) | 6 m (baseline)/12 /18 /24 m | (1) Twice daily tooth-brushing+ 0.12% chlorhexidine gel, once daily | No product+ twice daily tooth-brushing | Percentage of children with ECC/ MS/LB | Test 1/test 2/control | |
| (2) Twice daily tooth-brushing+ 10% CPP-ACP paste, once daily | Number with caries/Total (%) | ||||||
| Test 1: 4/180 (2%) | |||||||
| Test 2: 2/163 (1%) | |||||||
| Control: 3/188 (2%) | |||||||
| Pukallus, M.L. (2013) | 61/58subjects(0-2y) | Newborn, 6/12/18/24 m | Twice daily low-dose fluoride toothpaste+ 0.12% chlorhexidine gel, once daily | Low-dose fluoride toothpaste tooth-brushing, twice daily | Percentage of children with ECC/ MS/LB | Test/control: | |
| Number with caries/Total (%) | |||||||
| Test: 3/61 (5%) | |||||||
| Control: 4/58 (7%) | |||||||
| Children with MS: 28(46%)/27(47%) | |||||||
| Children with LB: 116(63%)/38(66%) | |||||||
| CPP-ACP | Sitthisettapong, T. (2012) | 117/112 subjects (2.5–3.5y) | Baseline, 6m, 1y | 10% CPP-ACP mousse + fluoride toothpaste | Placebo toothpaste + fluoride toothpaste | Clinical assessmentwith ICDAS criteria | Test 1/ test 2/ control (Mean±SD) |
| Baselineto12month (No progression/ progression): OR: 1.002, 95%CI (0.86,1.17) | |||||||
| Memarpor, M. (2015) | 30/29/31/32 subjects (1-3y) | Baseline, 4,8,12m | (1) Oral hygiene and CPP-ACP mousse, twice a day | Control (no treatment) | Change in mean WSL size and change in dmft index | Test1/teat 2/control 1/control 2 | |
| (2) Oral hygiene and 5% NaF vanish | Baseline to 12 m: -0.63±0.62/-0.51±10.56/-0.1±1.12/1.15±1.26 | ||||||
| (3) Oral hygiene +diet counselling | Dmft index: | ||||||
| 12 m: 0.17±0.53/0.3±0.9/0.42±0.99/2±2 | |||||||
| Triclosan | Cao, H.Z. (2007) | 296/265 subjects (2–5 y) | Baseline, 1 y | 0.3% triclosan vanish, twice a year | Control (no treatment) | Dmft and dmfs scores | Test/control (Mean ±SD) |
| Dmft | |||||||
| Baseline: 0.98±2.11/0.93±2.06 | |||||||
| 12m: 1.34±2.60/1.72±2.82 | |||||||
| dmfs | |||||||
| Baseline: 1.24±2.60/1.18±2.28 | |||||||
| 12m: 1.47±2.54/2.11±2.93 | |||||||
| Xylitol | Oscarson, P. (2006) | 55/63subjects(2-4y) | Baseline, 24m | Xylitol tablet, once per day. Two tablet per day after 6 m. This intervention was terminated when children was 3.5 yrs old | No tablet | defs score and salivary MS level | Test/control |
| Baseline: Number with caries/total (%) | |||||||
| Test: 4/66 (6%) | |||||||
| Control: 4/55 (7%) | |||||||
| 24m dmfs: 0.8±2.8 / 1.2±3.5 | |||||||
| Zhan, L. (2012) | 20/17subjects(6-35m) | Baseline, 3,6,12m | Xylitol wipe,6 wipes daily+ tooth brushing | Placebo wipe | defs score and salivary MS and LB level | Number with caries/Total (%) | |
| Test: 1/20 (5%) | |||||||
| Control: 6/17 (35%) | |||||||
| MS level (Test/control): | |||||||
| Baseline: 1.25±2.28/1.1±2.0 | |||||||
| 1yr: 1.25±2.63/3.38±2.75 | |||||||
| LB level (Test/control): | |||||||
| Baseline: 0.14±0.65/0.07±0.34 | |||||||
| 1yr: 0.11±0.48/0.53±1.21 | |||||||
| Lee, W. (2015) | 122/138 subjects (5-6y) | Baseline, 30m | Xylitol gummy bear, 3 times per day | Placebo gummy bear | dmfs score | Test/control | |
| New d3-6mfs: 5.0±7.6/4.0±6.5 | |||||||
| New d1-6mfs: 5.7±7.6/4.7±6.7 |
CaviStat®: an arginine bicarbonate calcium carbonate complex; WS: white spot; WSL: white spot lesion; F:fluoride; defs: decayed, extracted, filled surfaces; dmfs: decayed, missing, filled surfaces; dmft: decayed, missing, filled tooth; VPI:Visible Plaque Index; ECC: Early Childhood Caries; MS: mutans streptococci; LB: lactobacilli; ICDAS:The International Caries Detection and Assessment System; m: month; y:year.
Fig 2Risk of bias summary.
Fig 3Levels of bias types.